UK facial biometric firm iProov chosen to help US Department of Homeland Security to enhance and secure cross-border passenger travel
iProov, a leading provider of biometric facial verification technology, today announced it has become the first British – and indeed overseas – company to be awarded a contract from the US Department of Homeland Security Science & Technology Directorate’s Silicon Valley Innovation Program (SVIP).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180416006084/en/
iProov CEO, Andrew Bud (Photo: Business Wire)
The contract has been awarded to iProov to help US Customs and Border Protection (CBP) improve the passenger entry operation process.
London-based iProov was founded in 2011 by CEO Andrew Bud. The company’s facial biometric technology, patented in the US and UK, is used by banks and governments around the world for secure customer onboarding, logon and authentication, to ensure new and returning users are genuine and guard against fraudulent attempts to gain access to personal data or use a stolen identity.
The contract iProov has won will see the company develop technology that aims to enhance cross-border passenger travel at unmanned ports of entries while reducing processing time. It could help US CBP quickly, accurately and reliably identify travellers as they process through US border crossings.
At the heart of this announcement is iProov’s Flashmark technology, deployed in its secure, cloud-based facial biometric verification system that can be accessed via a user’s mobile phone. In this case, iProov’s technology will work with existing CBP systems, on which travellers’ details are pre-registered. In the run up to arrival at the US border, whether at home or en route, travellers would be able to self-serve the document check that normally happens at the point of border crossing, by authenticating themselves securely to their pre-registered photo, via their mobile phone. The process is simple, much quicker than waiting in line, and more secure than traditional methods.
Dr. Liam Fox, Secretary of State for the UK Department for International Trade, commented, “The UK and US are world leaders in cyber security. Through close cooperation across various sectors, trade between the two countries has grown to £181.2 billion pounds in 2017 - making the US our largest trading partner and biggest export market.
“One example of our shared economic and security ties is UK based iProov technology, which uses cutting-edge facial biometric verification technology to enhance security and deter those who seek to cause harm. It is now used by a range of institutions across the world and will soon be used by the US Customs and Border Protection, helping to enhance the way it processes people through US borders.”
The reason iProov was selected comes down to its ability to detect ‘spoofs’. In a self-serve identity verification environment, the system must be able to confirm whether or not the person presenting themselves for verification is genuinely the owner of the ID credential, not a photo, screen image or doctored video. iProov has ten granted patents in the UK and US for the technology that can detect these spoofs, and in this way is uniquely able to help governments tackle the pressure they are under from increased traveller numbers to swiftly but securely verify each and every traveller.
It is this growth in international travel which led the DHS S&T Directorate’s SVIP to look for partners to help tackle the cross-border passenger entry operation process. Over 112 million passengers enter the United States annually and over 1 million attempt to pass through its borders each day, increasing the pressure on Customs and Border Protection to facilitate the entry of international visitors, increase tourism and foster economic growth while ensuring the highest level of security.
iProov’s CEO, Andrew Bud, who will be speaking about the contract win while part of a UK trade delegation with the UK’s Department for International Trade to global cyber security conference RSA in San Francisco, commented, “We are delighted that iProov has been selected by the US Department of Homeland Security to enhance the way in which it processes people through US borders. Advances in machine learning and AI have enabled a revolution in facial biometrics in the last few years and we’re now seeing more and more cases of governments and banks turning to self-service, spoof-resilient face verification as the biometric of choice to both increase security and ensure ease of use.”
This is not the first time iProov has been recognised for its industry leading identity verification technology. The company won the 2017 National Cyber Security Centre’s Cyber Dragon’s Den competition at CYBERUK 2017; it has received a number of grants from Innovate UK, the UK's innovation agency; and in September 2017 was named the sole UK member of the SINET16, a select group of cyber-security innovators. In the financial services sector its technology is in live use with banks such as DNB in Norway and Rabobank in the Netherlands.
Founded in 2011 by CEO Andrew Bud, iProov is a world leader in spoof-resistant, biometric facial verification technology. Its technology is used by banks and governments around the world for secure customer onboarding, logon and authentication, to ensure new and returning users are genuine and guard against fraudulent attempts to gain access to personal data or use a stolen identity. For more information, please see www.iproov.com
+44 7833 474 447
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
PSE: APM Forum 2018 Focus on Digitalisation for the Process Industries20.4.2018 15:13 | Pressemelding
At the 2018 Advanced Process Modelling (APM) Forum this week, process industry organisations presented on digital design and operations applications ranging from accelerating development of the next generation of pharmaceuticals to realising millions of dollars per year in increased profit for large process plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005517/en/ Ben Weinstein, head of R&D Product and Process Systems Modeling at Procter & Gamble, delivers the keynote speech on how digital design techniques are used systematically to accelerate innovation in P&G. (Photo: Business Wire) Introducing the conference, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), described the current wave of digitalisation as the culmination of many years of advanced modelling and IT development. “This is a time of extraordinary opportunities for the process industries” he said. Keynote speaker Ma
Aperta Provides Electronic Funds Transfer (EFT) in Cayman Islands20.4.2018 14:01 | Pressemelding
Once again, the Aperta Active Clearing System (ACS) has delivered the mechanism for a country to implement a world-class electronic payment processing environment to maximize a national payments system’s efficiency, effectiveness, security and control. Aperta partnered with the Cayman Islands ACH Operator (Prism Services (Cayman) Ltd.) and local commercial banks to deliver a new Electronic Funds Transfer system. The old process of banks swapping files in a wide-variety of standards and settling bilaterally has been replaced with a common system and standards, employing international-standard secure file transfer protocol, allowing participants to monitor real time net settlement and collateral positions via a secure portal. The Cayman Islands Automated Clearinghouse (CIACH) links all six of the country’s banks and provides the central clearing and settlement mechanism for banks to exchange direct debit and direct credit transactions seamlessly across the country. It is functionally NAC
FII Tech Growth Invests in SECO20.4.2018 13:39 | Pressemelding
FII Tech Growth, a fund managed by Fondo Italiano d’Investimento SGR, announces today its second investment in SECO SpA, one of the European leaders in the embedded electronics market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005413/en/ (Photo: SECO) SECO, headquartered in Arezzo, Tuscany, with subsidiaries in the U.S.A., Germany and Taiwan, was founded in 1979 by entrepreneurs Daniele Conti and Luciano Secciani. The company designs and manufactures micro-computers and integrated systems for industrial applications. With more than 250 employees, SECO supports customers with a worldwide presence such as Cimbali, Esaote, Technogym and Vimar, and generated revenue in excess of Euro 50 million in 2017. The ability to offer innovative solutions by using cutting-edge technologies has allowed SECO to grow steadily over time. The company developed a network of collaborations with universities and research centres La Sapi
Schlumberger Announces First-Quarter 2018 Results20.4.2018 11:05 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the first quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2018 Dec. 31, 2017 Mar. 31, 2017 Sequential Year-on-year Revenue $7,829 $8,179 $6,894 -4% 14% Pretax operating income $974 $1,155 $757 -16% 29% Pretax operating margin 12.4% 14.1% 11.0% -169 bps 145 bps Net income (loss) - GAAP basis $525 $(2,255) $279 n/m 88% Net income, excluding charges & credits* $525 $668 $347 -21% 51% Diluted EPS (loss per share) - GAAP basis $0.38 $(1.63) $0.20 n/m 90% Diluted EPS, excluding charges & credits* $0.38 $0.48 $0.25 -21% 52% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “As forecast, our results in the first quarter of 2018 largely reflected transitory factors, with seasonal reductions in activity in the Northern Hemisphere and planned project startup costs
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases20.4.2018 10:30 | Pressemelding
Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below. Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an appr
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f